InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Browse the complete record of transactions filed by Jafri Hasan, Directeur Médical. Officer active across 1 company, notably Aridis Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been recorded. Split: 1 buy · 0 sell. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Hasan Jafri serves as the Chief Medical Officer at Aridis Pharmaceuticals, Inc. In this role, he is responsible for leading the company's medical and clinical initiatives, which focus on developing innovative treatments for infectious diseases. Hasan plays a crucial role in Aridis's research and development strategy, contributing to the advancement of therapeutic solutions. His medical expertise is essential for the company's success.